HSBC Holdings’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

HSBC Holdings’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-6,423	Closed	-$266K	–	2296
2015 Q2	$266K	Sell	6,423 -253	-4%	-$9.07K	﹤0.01%	1674
2015 Q1	$235K	Buy	+6,676	New	+$226K	﹤0.01%	1857

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

HSBC Holdings's BRLI Position: Q3 2015 in Review

HSBC Holdings sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 6,423 shares — an estimated $266K sold.

HSBC Holdings first reported a position in BRLI in Q1 2015 and held it in 2 quarters. The position peaked at $266K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

HSBC Holdings reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
HSBC Holdings sold 6,423 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $266K.
HSBC Holdings first reported a position in BIO-REFERENCE LABS INC-NEW- in Q1 2015 and held it in 2 quarters.
HSBC Holdings's BIO-REFERENCE LABS INC-NEW- position peaked at $266K in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on HSBC Holdings's 13F filing for Q3 2015, filed 12 Nov 2015.